As of 2024-12-12, the EV/EBITDA ratio of Orthofix Medical Inc (OFIX) is -20.96. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OFIX's latest enterprise value is 815.59 mil USD. OFIX's TTM EBITDA according to its financial statements is -38.92 mil USD. Dividing these 2 quantities gives us the above OFIX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 15.0x | 12.9x |
| Forward P/E multiples | 13.1x - 19.0x | 14.4x |
| Fair Price | (16.15) - (18.06) | (16.68) |
| Upside | -187.1% - -197.4% | -190.0% |
| Date | EV/EBITDA |
| 2024-11-29 | -21.93 |
| 2024-11-27 | -21.54 |
| 2024-11-26 | -21.74 |
| 2024-11-25 | -21.45 |
| 2024-11-22 | -21.32 |
| 2024-11-21 | -21.09 |
| 2024-11-20 | -21.28 |
| 2024-11-19 | -21.14 |
| 2024-11-18 | -20.71 |
| 2024-11-15 | -20.51 |
| 2024-11-14 | -20.03 |
| 2024-11-13 | -21.05 |
| 2024-11-12 | -21.65 |
| 2024-11-11 | -22.41 |
| 2024-11-08 | -21.81 |
| 2024-11-07 | -20.64 |
| 2024-11-06 | -20.82 |
| 2024-11-05 | -20.14 |
| 2024-11-04 | -19.77 |
| 2024-11-01 | -19.41 |
| 2024-10-31 | -18.65 |
| 2024-10-30 | -18.81 |
| 2024-10-29 | -18.82 |
| 2024-10-28 | -18.64 |
| 2024-10-25 | -18.35 |
| 2024-10-24 | -18.26 |
| 2024-10-23 | -18.14 |
| 2024-10-22 | -18.49 |
| 2024-10-21 | -18.66 |
| 2024-10-18 | -18.51 |
| 2024-10-17 | -18.35 |
| 2024-10-16 | -18.48 |
| 2024-10-15 | -18.13 |
| 2024-10-14 | -18.56 |
| 2024-10-11 | -18.05 |
| 2024-10-10 | -17.48 |
| 2024-10-09 | -17.56 |
| 2024-10-08 | -17.58 |
| 2024-10-07 | -17.57 |
| 2024-10-04 | -17.77 |
| 2024-10-03 | -17.73 |
| 2024-10-02 | -18.02 |
| 2024-10-01 | -17.77 |
| 2024-09-30 | -18.09 |
| 2024-09-27 | -17.80 |
| 2024-09-26 | -17.85 |
| 2024-09-25 | -17.86 |
| 2024-09-24 | -18.08 |
| 2024-09-23 | -18.37 |
| 2024-09-20 | -18.67 |